Abstract
Pro-survival BCL-2 family proteins are potent inhibitors of apoptosis and are often overexpressed in lymphoid malignancies. In multiple myeloma (MM), BCL-2 inhibitor Venetoclax induces cell death, particularly in presence of t(11;14) and high BCL-2 expression. The most prominent BCL-2 family member in MM is MCL-1, whose expression contributes to survival of malignant plasma cells and overexpression correlates with poor prognosis. Amplification of 1q21, the chromosome region that contains the MCL1 locus, occurs in approximately 40% of newly diagnosed MM, and 70% at relapse.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
